Utah Medical Products extends tender offer for Utah Medical Products stock
Published on 10/07/2026 at 01:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Utah Medical Products extended its tender offer on October 5, 2026, moving the deadline to October 27, 2026. Utah Medical Products stock was last at EUR 63.00 in Frankfurt on October 2, 2026 at 8:01 a.m. CEST, while the latest Nasdaq quote was USD 73.83 on October 6, 2026 at 4:00 p.m. ET.
Offer deadline moves to October 27
According to StockTitan on October 5, 2026, the company will purchase up to 650,000 common shares at USD 75.00 per share. The new expiration date is October 27, 2026, replacing the prior October 7 deadline.
The extension gives holders more time to assess the company's scheduled calendar third-quarter 2026 results on October 22, 2026. The offer price represents a 17.00 percent premium to the average daily closing price over the preceding 12 months, according to the September 2026 tender-offer communication reported by StockTitan.
Operating weakness raises the stakes
The tender timing matters because first-half 2026 sales were 12.00 percent lower than in the first half of 2025, while net profit declined 13.00 percent over the same comparison, according to StockTitan. That contrast puts the October 22 results date alongside the USD 75.00 offer as the central valuation reference for the next phase.
Utah Medical Products develops and manufactures specialty medical devices, including products for labor and delivery, neonatal care, women's health and related hospital procedures. Its investor-relations page says the common stock trades on the Nasdaq Global Market under the symbol UTMD, and the company emphasizes earnings per share growth and return on shareholder equity.
Stock stays below the offer price
UTMD was last at USD 73.83 on Nasdaq on October 6, 2026 at 4:00 p.m. ET. The quote was below the USD 76.89 52-week high and above the USD 53.66 52-week low, while market capitalization stood at USD 235.1 million on the same date.
Utah Medical Products stock facts
- Company: Utah Medical Products, Inc.
- ISIN: US9174881089
- Ticker: UTMD
- Primary exchange: Nasdaq Global Market
- Substitute price Frankfurt (as of October 2, 2026, 8:01 a.m. CEST): EUR 63.00
- Market capitalization: USD 235.1 million (as of October 6, 2026)
- 52-week range: USD 53.66-76.89 (as of October 6, 2026)
- Sector / Industry: Healthcare / Medical Instruments and Supplies
- Next earnings date: October 22, 2026
More news and analyses on Utah Medical Products stock are available through the Utah Medical Products stock topic page.
